Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Waterfall Scientific is a Massachusetts-based biotechnology platform company pioneering continuous-flow technologies for mRNA manufacturing. Spun out of the University of Massachusetts Amherst, the company commercializes its proprietary DuoTether continuous-flow system, which functionally co-immobilizes the DNA template and RNA polymerase enzyme to a solid surface. This approach enables the continuous synthesis of high-purity mRNA, dramatically reducing double-stranded RNA (dsRNA) impurities and eliminating the need for extensive downstream purification. In September 2026, Waterfall Scientific was awarded up to $54.5 million by ARPA-H to lead the ESCALATOR consortium, aiming to develop a fully automated, benchtop, continuous-flow system for end-to-end, on-demand production of RNA drug products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Waterfall Scientific.